AI is a game of kings, and OpenAI knows it
MOBILE, Ala. - TruBridge (NASDAQ:TBRG), a provider of revenue cycle management and healthcare technology solutions for rural and community healthcare organizations, has appointed Michael Daughton as Chief Business Officer, effective October 6, 2025. The company, with a market capitalization of $297 million and annual revenue of $346 million, maintains a healthy gross margin of 52.5% and has received a "GOOD" financial health rating according to InvestingPro analysis.
In his new role, Daughton will oversee client-centered excellence and growth, reporting directly to Chris Fowler, president and chief executive officer of the company.
Daughton brings 30 years of healthcare industry experience to TruBridge. He previously spent over a decade with MModal and AQuity, where he led commercial initiatives that resulted in several transactions, including 3M’s $1 billion acquisition of MModal’s technology business and AQuity’s acquisition by IKS Health. His career also includes sales leadership positions at Optum and most recently serving as Chief Commercial Officer at EnableComp.
"I am excited to welcome Mike Daughton to the TruBridge team," said Fowler in the announcement. "His reputation for building high-performing teams and consistently delivering enterprise value and measurable impact for investors and clients made him the perfect fit for this role."
TruBridge currently serves over 1,500 clients nationwide, offering technology, services, and strategic expertise including revenue cycle management, electronic health records, and analytics designed for rural and community healthcare providers. The company’s stock has demonstrated strong momentum, delivering a 72.5% return over the past year, while three analysts have recently revised their earnings expectations upward. According to InvestingPro analysis, the stock appears undervalued at current levels.
The appointment comes as healthcare providers in rural and community settings continue to face operational challenges. According to the press release statement, TruBridge aims to help these facilities maintain independence while providing quality care to their local communities. For detailed insights into TruBridge’s valuation, financial health metrics, and growth prospects, investors can access the comprehensive Pro Research Report available on InvestingPro, which covers over 1,400 US stocks with expert analysis and actionable intelligence.
In other recent news, TruBridge, Inc. has announced an agreement with Java Medical Group to implement its technology and services at Russellville Hospital in Alabama. This partnership is part of an ongoing effort to standardize Java Medical Group’s managed hospitals, utilizing TruBridge’s nTrust offering, which features electronic health records and financial health software. This collaboration follows a similar project completed at Unity Medical Center in Tennessee, aiming to enhance workflow and outcomes. Additionally, Cantor Fitzgerald has reiterated its Overweight rating on TruBridge, maintaining a price target of $29.00. The research firm remains optimistic about TruBridge’s sales pipeline, noting positive signals that extend into 2026. These developments highlight TruBridge’s strategic initiatives and the continued confidence from analysts in its future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.